21 research outputs found

    Cognitive performance in asymptomatic carriers of mutations R1031C and R141C in CADASIL

    Get PDF
    CADASIL is the most common hereditary cause of repeated ischemic strokes, and has also been identified as a model of pure vascular dementia. The objective of this study was to establish the cognitive performance of asymptomatic carriers with the mutations R1031C and R141C. This observational cross-sectional analytical study divided subjects into three groups: asymptomatic carriers of the R1031C mutation (n = 39), asymptomatic carries of the R141C mutation (n = 8) and non-carriers (n = 50). Statistically significant differences were found (p <0.05) between the group of the R1031C mutation and the non-carriers in constructional praxis, executive function and abstract reasoning. For the R141C mutation, scores below expected values in executive function and mental calculation were observed. It is concluded that asymptomatic carriers of the two mutations showed low performance in working memory, mental abstraction and processing speed, which could be associated with preclinical cognitive biomarkers preceding the presentation of the first vascular event

    Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report.

    Get PDF
    We identified a PSEN1 (presenilin 1) mutation carrier from the world's largest autosomal dominant Alzheimer's disease kindred, who did not develop mild cognitive impairment until her seventies, three decades after the expected age of clinical onset. The individual had two copies of the APOE3 Christchurch (R136S) mutation, unusually high brain amyloid levels and limited tau and neurodegenerative measurements. Our findings have implications for the role of APOE in the pathogenesis, treatment and prevention of Alzheimer's disease

    Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study.

    Get PDF
    Each additional copy of the apolipoprotein E4 (APOE4) allele is associated with a higher risk of Alzheimer's dementia, while the APOE2 allele is associated with a lower risk of Alzheimer's dementia, it is not yet known whether APOE2 homozygotes have a particularly low risk. We generated Alzheimer's dementia odds ratios and other findings in more than 5,000 clinically characterized and neuropathologically characterized Alzheimer's dementia cases and controls. APOE2/2 was associated with a low Alzheimer's dementia odds ratios compared to APOE2/3 and 3/3, and an exceptionally low odds ratio compared to APOE4/4, and the impact of APOE2 and APOE4 gene dose was significantly greater in the neuropathologically confirmed group than in more than 24,000 neuropathologically unconfirmed cases and controls. Finding and targeting the factors by which APOE and its variants influence Alzheimer's disease could have a major impact on the understanding, treatment and prevention of the disease

    Factores genéticos y no-genéticos asociados a CADASIL: estudio de cohorte retrospectivo

    No full text
    ABSTRACT: Objective: To examine the relationships between genetic variables (genotype–phenotype) and cardiovascular risk factors in the natural history of CADASIL. Methods: This was a retrospective cohort study of 331 individuals, 90 were carriers of four mutations in the NOTCH3 gene. Cox proportional hazards models were fitted to estimate the effect of genetic and cardiovascular factors on the onset of migraine, first stroke, and dementia. Competing risk regression models considered death as risk. Results: Noncarriers and NOTCH3 mutation carriers had similar frequencies for all cardiovascular risk factors. Diabetes (SHR 3.5, 95% CI 1.75–7.15) was associated with a younger age at onset of strokes among carriers. Additionally, a genotype–phenotype relationship was observed among C455R mutation carriers, with higher frequency of migraines (100%), younger age at onset of migraine (median age 7 years, IQR 8) and cerebrovascular events (median age 30.5 years, IQR 26). Moreover, fewer carriers of the R141C mutation exhibited migraines (20%), and it was even lower than the frequency observed in the noncarrier group (44.8%). Conclusions: This study characterizes extended family groups, allowing us a comparison in the genotype–phenotype. The results suggest a complex interplay of genetic and cardiovascular risk factors that may help explain the variability in the clinical presentation and severity of CADASILRESUMEN: Objetivo: Examinar las relaciones entre variables genéticas (genotipo-fenotipo) y factores de riesgo cardiovascular en la historia natural de CADASIL. Métodos: Este fue un estudio de cohorte retrospectivo de 331 individuos, 90 eran portadores de cuatro mutaciones en el gen NOTCH3. Se ajustaron modelos de riesgos proporcionales de Cox para estimar el efecto de factores genéticos y cardiovasculares sobre la aparición de migraña, primer accidente cerebrovascular y demencia. Los modelos de regresión de riesgo en competencia consideraron la muerte como riesgo. Resultados: Los no portadores y los portadores de la mutación NOTCH3 tuvieron frecuencias similares para todos los factores de riesgo cardiovascular. La diabetes (SHR 3,5; IC del 95%: 1,75 a 7,15) se asoció con una edad más temprana al inicio de los accidentes cerebrovasculares entre los portadores. Además, se observó una relación genotipo-fenotipo entre los portadores de la mutación C455R, con mayor frecuencia de migrañas (100%), menor edad al inicio de la migraña (mediana de edad de 7 años, IQR 8) y eventos cerebrovasculares (mediana de edad de 30,5 años, IQR 26 ). Además, menos portadores de la mutación R141C presentaron migrañas (20%), y fue incluso menor que la frecuencia observada en el grupo no portador (44,8%). Conclusiones: Este estudio caracteriza a los grupos familiares extensos, lo que nos permite una comparación en el genotipo-fenotipo. Los resultados sugieren una interacción compleja de factores de riesgo genéticos y cardiovasculares que pueden ayudar a explicar la variabilidad en la presentación clínica y la gravedad de CADASIL

    Specific Abnormalities in White Matter Pathways as Interface to Small Vessels Disease and Cognition in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Individuals

    No full text
    Background: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is characterized by leukoencephalopathy leading to cognitive impairment. Subtle cognitive deficits can be observed early in the course of the disease, before the occurrence of the first stroke. Therefore, markers that can predict disease progression at this early stage, when interventions are likely to alter disease course, are needed. We aimed to examine the biological cascade of microstructural and macrostructural white matter (WM) abnormalities underlying cognitive deficits in CADASIL.Methods: We examined 20 nondemented CADASIL mutation carriers and 23 noncarriers who underwent neuropsychological evaluation and magnetic resonance imaging. Using probabilistic tractography of key WM tracts, we examined group differences in diffusivity measures and WM hyperintensity volume. Successive mediation models examined whether tract-specific WM abnormalities mediated subtle cognitive differences between CADASIL mutation carriers and noncarriers.Results: The largest effect size differentiating the two groups was observed for left superior longitudinal fasciculus-temporal (SLFt) diffusivity (Cohen's f = 0.49). No group differences were observed with a global diffusion measure. These specific microstructural differences in the SLFt were associated with higher WM hyperintensities burden, and subtle executive deficits in CADASIL mutation carriers.Discussion: Worse diffusivity in the left SLFt is related to greater severity of small vessel disease and worse executive functioning in the asymptomatic stage of the disease. Worse diffusivity of the left SLFt may potentially hold promise as an indicator of disease progression. Impact statementDiffusion tensor imaging outperforms conventional imaging of subcortical small vessel disease as a potential marker of future disease progression. Here we identified the left superior longitudinal temporal fasciculus as a critical white matter fiber bundle, of which worse diffusivity can link presence of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy mutations to greater severity of small vessel disease and worse executive functioning in asymptomatic stages of the disease. This tract may hold promise and deserves further examination as an early indicator of disease progression
    corecore